Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Sabbagh

Showing results (301-310 of 330) with videos related to

Pageof 33
Sort By:
Frontiers in Aging Neuroscience|September 26, 2019
Age-Dependent Relationship Between Plasma Aβ40 and Aβ42 and Total Tau Levels in Cognitively Normal SubjectsLih-Fen Lue, Ming-Chyi Pai, Ta-Fu Chen, et al.
Frontiers in Aging Neuroscience|November 23, 2019
Corrigendum: Age-Dependent Relationship Between Plasma Aβ40 and Aβ42 and Total Tau Levels in Cognitively Normal SubjectsLih-Fen Lue, Ming-Chyi Pai, Ta-Fu Chen, et al.
The Lancet. Neurology|July 4, 2012
Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort studyChristopher M Clark, Michael J Pontecorvo, Thomas G Beach, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 5, 2013
Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal agingKeith A Johnson, Reisa A Sperling, Christopher M Gidicsin, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 1, 2015
Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: phase 3 studyOsama Sabri, Marwan N Sabbagh, John Seibyl, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 3, 2009
Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's diseaseAlex E Roher, Chera L Esh, Tyler A Kokjohn, et al.
Journal of Internal Medicine|January 18, 2021
Practical recommendations for timely, accurate diagnosis of symptomatic Alzheimer's disease (MCI and dementia) in primary care: a review and synthesisJ L Liss, S Seleri Assunção, J Cummings, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 22, 2021
Brain structures and networks responsible for stimulation-induced memory flashbacks during forniceal deep brain stimulation for Alzheimer's diseaseJürgen Germann, Gavin J B Elias, Alexandre Boutet, et al.
JAMA Neurology|May 9, 2022
Safety, Tolerability, and Immunogenicity of the ACI-24 Vaccine in Adults With Down Syndrome: A Phase 1b Randomized Clinical TrialMichael S Rafii, Olivier Sol, William C Mobley, et al.
Neurology and Therapy|October 17, 2023
Roadmap for C9ORF72 in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis: Report on the C9ORF72 FTD/ALS SummitRita Sattler, Bryan J Traynor, Janice Robertson, et al.
Pageof 33

Showing results (301-310 of 330) with videos related to

Sort By:
Pageof 33
Frontiers in Aging Neuroscience|September 26, 2019
Age-Dependent Relationship Between Plasma Aβ40 and Aβ42 and Total Tau Levels in Cognitively Normal SubjectsLih-Fen Lue, Ming-Chyi Pai, Ta-Fu Chen, et al.
Frontiers in Aging Neuroscience|November 23, 2019
Corrigendum: Age-Dependent Relationship Between Plasma Aβ40 and Aβ42 and Total Tau Levels in Cognitively Normal SubjectsLih-Fen Lue, Ming-Chyi Pai, Ta-Fu Chen, et al.
The Lancet. Neurology|July 4, 2012
Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort studyChristopher M Clark, Michael J Pontecorvo, Thomas G Beach, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 5, 2013
Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal agingKeith A Johnson, Reisa A Sperling, Christopher M Gidicsin, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 1, 2015
Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: phase 3 studyOsama Sabri, Marwan N Sabbagh, John Seibyl, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 3, 2009
Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's diseaseAlex E Roher, Chera L Esh, Tyler A Kokjohn, et al.
Journal of Internal Medicine|January 18, 2021
Practical recommendations for timely, accurate diagnosis of symptomatic Alzheimer's disease (MCI and dementia) in primary care: a review and synthesisJ L Liss, S Seleri Assunção, J Cummings, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 22, 2021
Brain structures and networks responsible for stimulation-induced memory flashbacks during forniceal deep brain stimulation for Alzheimer's diseaseJürgen Germann, Gavin J B Elias, Alexandre Boutet, et al.
JAMA Neurology|May 9, 2022
Safety, Tolerability, and Immunogenicity of the ACI-24 Vaccine in Adults With Down Syndrome: A Phase 1b Randomized Clinical TrialMichael S Rafii, Olivier Sol, William C Mobley, et al.
Neurology and Therapy|October 17, 2023
Roadmap for C9ORF72 in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis: Report on the C9ORF72 FTD/ALS SummitRita Sattler, Bryan J Traynor, Janice Robertson, et al.
Pageof 33